RxDoctor Payments Data

Steven Zorn, MD

Sleep Medicine · West Des Moines, IANPI 1407819816

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.6% of the total across 142 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 41.4% of the total.

$3,504in general payments, 2019–2025

Across 142 payments — averaging $24.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$1K
  • Harmony Biosciences LLC$522
  • Axsome Therapeutics, Inc.$521
  • Avadel CNS Pharmaceuticals, LLC$363
  • Eisai Inc.$164
  • Itamar Medical Inc$115
  • plus $370 from 7 others

What the payments were for

  • Food & beverage$3,31695%
  • Education$1885%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few sleep medicine providers in Iowato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$89,926
Medicare patients
451
Services billed
593

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Armodafinil32$2,452
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine14$1,744
Methylphenidate Hcl52$1,322
Doxepin Hcl76$1,138
Modafinil32$1,084
Methylphenidate ErMethylphenidate Hcl21$1,051
Eszopiclone65$895
Temazepam56$853
Zolpidem Tartrate118$779
Clonazepam84$648
Pramipexole DihydrochloridePramipexole Di-Hcl79$586
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine11$539
Gabapentin24$344
Ropinirole Hcl31$333
Montelukast Sodium17$106

Paid to pharmacies, not to this prescriber.

Other sleep medicine in West Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →